RCOR1 and cancer: Inhibition with phenelzine or EPI-111, but not GSK, inhibited nLSD1p and CoREST nuclear localization and colocalization in MDA-MB-231 cells and an immunotherapy-resistant melanoma (B16) cancer cell line (Figure 1H, Supplementary Figure 1F).